Newport Beach Clinical Research Associates, Inc. Report issue

For profit Phase 3
Founded: Newport Beach CA United States (2002)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2014
NCT02083783
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

amphetamine (Adderall) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Attention Deficit Disorder with Hyperactivity (Phase 3)

Hyperkinesis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1